This result suggests that tumor growth, MDSCs increase, and increase in CXCR2 expression could be related and part of the tumor’s immune evasion and suppression strategies, which might be a result of tumor-induced systemic change on cytokine levels that warrant further study. The gene discussed is CXCR2; the disease is neoplasm.